Ernest Loumaye
Fondateur chez OBSEVA SA
Fortune : 69 800 $ au 30/04/2024
Postes actifs de Ernest Loumaye
Sociétés | Poste | Début | Fin |
---|---|---|---|
OBSEVA SA | Président | 13/03/2023 | - |
Fondateur | 14/11/2012 | - | |
Directeur/Membre du Conseil | 14/11/2012 | 13/03/2023 | |
Directeur Général | 14/11/2012 | 01/12/2020 | |
Directeur Technique/Scientifique/R&D | 14/11/2012 | 22/09/2015 |
Historique de carrière de Ernest Loumaye
Anciens postes connus de Ernest Loumaye
Sociétés | Poste | Début | Fin |
---|---|---|---|
Ava AG
Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Directeur/Membre du Conseil | 01/09/2019 | 01/01/2021 |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Président | 26/05/2011 | 01/01/2016 |
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Directeur Général | 01/06/2006 | 01/10/2012 |
Fondateur | 29/07/2009 | 01/10/2012 | |
IPSEN | Corporate Officer/Principal | 01/01/2003 | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
Formation de Ernest Loumaye
Université Catholique de Louvain | Doctorate Degree |
Statistiques
Internationale
Suisse | 6 |
Belgique | 2 |
France | 2 |
Opérationnelle
Chief Executive Officer | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
OBSEVA SA | Health Technology |
IPSEN | Health Technology |
Entreprise privées | 4 |
---|---|
PregLem SA
PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Calliditas Therapeutics Suisse SA
Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
Ava AG
Ava AG Miscellaneous Commercial ServicesCommercial Services Ava AG develops and offers a fertility band that allows for birth control. It offers a bracelet that indicates days on which it is possible to become pregnant. The company was founded by Lea von Bidder, Peter Stein, Philipp Tholen and Pascal Koenig in 2014 and is headquartered in Zurich, Switzerland. | Commercial Services |
- Bourse
- Insiders
- Ernest Loumaye
- Expérience